550 related articles for article (PubMed ID: 1695855)
1. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
Voss R; Matthias FR; Borkowski G; Reitz D
Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
[TBL] [Abstract][Full Text] [Related]
2. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
[TBL] [Abstract][Full Text] [Related]
4. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation and fibrinolysis during normal pregnancy.
van Wersch JW; Ubachs JM
Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):45-50. PubMed ID: 1904779
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
Vaziri ND; Gonzales EC; Wang J; Said S
Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease.
Vaziri ND; Winer RL; Gonzales EV; Eltorai IM
J Am Paraplegia Soc; 1993 Jul; 16(3):149-52. PubMed ID: 7690062
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
9. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases.
Kummer JA; Abbink JJ; de Boer JP; Roem D; Nieuwenhuys EJ; Kamp AM; Swaak TJ; Hack CE
Arthritis Rheum; 1992 Aug; 35(8):884-93. PubMed ID: 1379429
[TBL] [Abstract][Full Text] [Related]
10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
11. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.
Comerota AJ; Chouhan V; Harada RN; Sun L; Hosking J; Veermansunemi R; Comerota AJ; Schlappy D; Rao AK
Ann Surg; 1997 Sep; 226(3):306-13; discussion 313-4. PubMed ID: 9339937
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
Cucuianu M; Knauer O; Roman S
Thromb Haemost; 1991 Nov; 66(5):586-91. PubMed ID: 1725069
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
Barton MH; Morris DD; Norton N; Prasse KW
J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
[TBL] [Abstract][Full Text] [Related]
16. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
17. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
[TBL] [Abstract][Full Text] [Related]
20. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
